Pharma
Join us in Munich for the 2nd Sustainable Medicine & Environment Summit on May 22-23, 2024, where industry leaders, researchers, and policymakers will explore the intersection of pharmaceutical manufacturing, technology, and environmental sustainability. Discover green solutions, renewable energy integration, and eco-friendly drug development. This exciting event brings together leaders, researchers, and policymakers to explore how pharmaceutical manufacturing and technology can be more sustainable.
Read moreDiscover the latest advancements in sustainable pharmaceutical processes, green chemistry applications, and resource-efficient drug development. Learn from experts about waste reduction, circular economy practices, and renewable energy integration in pharma facilities. We'll explore green packaging alternatives and delve into water conservation and management strategies for the pharmaceutical industry.
Delve into lifecycle assessments of pharmaceuticals and embrace green practices to make a positive impact on the environment.
Connect with like-minded professionals to discuss eco-friendly drug delivery systems and the crucial role of biodiversity in human health. Explore how the One Health approach can lead to groundbreaking collaborations between medicine, the environment, and technology.
Executives, Directors, Heads, Leaders, Managers, Specialists, Engineers Professionals in Pharmaceuticals, Principal Scientists, Sustainable Regulatory, QC Laboratories, Manufacturers of Drug Substances (APIs), Contract Laboratories, Health & Human Services, Clinical Research Org., Healthcare Packaging, Contract Research Org., Contract Manufacturing Org., Biopharma Companies, Biotechnology Prod., and Fellows specialising in:
To request an agenda for this Summit, please complete the details below. We will send you the agenda via email.
About Speaker
About Speaker
About Speaker
About Speaker
Novartis has set ambitious environmental sustainability targets to achieve carbon neutral own operations by 2025, plastic neutrality and water sustainability by 2030, and net-zero by 2040.
Jürgen’s role as environmental sustainability lead for global drug development covers the set-up and execution of low carbon clinical trials. On top, Jürgen is in charge of the company-wide target of “all new products meet sustainable design principles by 2030”, which spans from research up to commercial.
Jürgen has been very engaged and passionate about the topic of environmental sustainability for more than three decades. Prior to joining Novartis in 2011, he was the CFO of the NGO Solar Energy Foundation, supporting the roll-out of solar energy in rural East Africa. From 2015-20, he was the finance head of Novartis’ global clinical supply unit, during which he was awarded with the Novartis “Better World Award for Environmental Sustainability” for significant progress in the decarbonisation of clinical trials. Jürgen contributes beyond Novartis within the UK-based Sustainable Healthcare Coalition to the industries’ low carbon clinical trial workstream.
Dr. Michael Hell is a chemist (MSc) and cell biologist (PhD) by education with substantial experience in manufacturing and operations of biopharmaceuticals. Before being appointed to head of sustainability at Merck’s Healthcare operations, he was leading environment, health, and safety for Merck KGaA’s global biotech manufacturing and led a packaging, logistics, and visual inspection operation unit.
Michael brings a diverse background in manufacturing, spanning environment, health, and safety, strategy development, continuous improvement/LEAN, operations, and business consulting. He is an active member of ISPE and chaired conference tracks or contributed as speaker. Michael co-authored scientific papers or book chapters.
Request the 2nd Sustainable Medicine & Environment Conference brochure and find out the latest topics and ideas that will be shared.
Please fill in your e-mail address below and we will process your request in a moment.
Pharma
Pharma
Pharma